Long-Term Debt (Quarterly)

Long-Term Debt: The sum of all long term debt fields.

Bio-Rad Laboratories, Inc. (BIO) had Long-Term Debt of $1.20B for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$653.00M
Net Income	$-341.90M
Cost of Goods Sold	$309.60M
Gross Profit	$343.40M
Operating Expenses	$587.70M
Operating Income	$65.30M
Non-Operating Income/Expense	$-496.40M
Pre-Tax Income	$-431.10M
Normalized Pre-Tax Income	$64.20M
Income after Taxes	$-341.90M
Income from Continuous Operations	$-341.90M
Consolidated Net Income/Loss	$-341.90M
Normalized Income after Taxes	$255.88M
EBIT	$65.30M
EBITDA	$65.30M
Weighted-Average Shares Outstanding (Basic)	26.92M
Weighted-Average Shares Outstanding (Diluted)	26.92M
Earnings per Share (EPS) (Basic)	$-12.70
Earnings per Share (EPS) (Diluted)	$-12.70
Balance Sheet Financials
Current Assets	$2.84B
Property, Plant, and Equipment	$540.20M
Long-Term Assets	$6.85B
Total Assets	$9.70B
Current Liabilities	$522.30M
Long-Term Debt	$1.20B
Long-Term Liabilities	$2.44B
Total Liabilities	$2.96B
Common Equity	$6.74B
Tangible Shareholders Equity	$5.77B
Shareholders Equity	$6.74B
Common Shares Outstanding	26.97M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$367.30M
Cash Flow from Investing Activities	$-155.50M
Cash Flow from Financial Activities	$-286.50M
Beginning Cash	$489.80M
End Cash	$398.20M
Increase/Decrease in Cash	$-91.60M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.44
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.15
Debt to Equity Ratio	0.18
Gross Margin	52.59%
Operating Margin	10.00%
EBIT Margin	10.00%
EBITDA Margin	--
Pre-Tax Profit Margin	-66.02%
Profit Margin	-52.36%
Free Cash Flow	$255.60M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.07
Inventory Turnover	0.40
Receiveable Turnover	1.41
Days Sales in Receivables	64.05
Return on Equity	-5.08%
Return on Tangible Equity	-5.93%
Return on Assets	-3.53%
Return on Investments	-4.31%
Book Value Per Share	$249.75
Free Cash Flow per Share	$9.49
Operating Cash Flow per Share	$13.64

Data from Zacks Investment Research, Inc.